Latest Financial Results
FY 2022
Fiscal Year Ended Dec 31, 2022
$1.14B
Total revenue of $1.14 billion, an increase of 48% from $773.9 million for the prior year$49M
Net income attributable to ApolloMed of $49.0 million$1.08
Earnings per share - diluted ("EPS – diluted") of $1.08For complete information regarding our financials, see our periodic filings